Vitalograph device used in study to determine role of pulmonary function in cardiometabolic endpoints

Published by Rhys Taylor-Brown on March 30th 2022, 12:00am

A recent study by Li G, et al. [2022] was carried out to assess how pulmonary function has different risk magnitudes for cardiometabolic diseases [CD] and cardiometabolic multimorbidity [CM].

The Vitalograph Pneumotrac, a powerful and flexible diagnostic device suitable for testing adults and paediatrics, was used to conduct parts of the study.

The exercise concluded that “pulmonary function could be used as a valuable predictor for the tailored prevention of individual cardiometabolic diseases and CM. Stratifying different high-risk populations through pulmonary function to implement precision medicine may have far-reaching clinical implications”.

Vitalograph offers respiratory clinical trials solutions including ECG devices and expert cardiac analysis to ensure accurate endpoint data such as QT/QTc, as well as providing timely interpretations and alerts to support safety monitoring of subjects throughout clinical trials.

The full report on the study of pulmonary function in cardiometabolic endpoints can be found here.


Photo by National Cancer Institute on Unsplash


Share this article


Leaders of Great Britain

About Leaders of Great Britain

Leaders of Great Britain hosts a series of engaging events featuring prominent figures from the worlds of politics, sports, business, and entertainment. Our goal is for every attendee to leave these gatherings with profound leadership insights that transcend boundaries. Learn More.


Related Features


Authored By

Rhys Taylor-Brown
Junior Editor
March 30th 2022, 12:00am

Follow Us

Follow @LeadersGBNI on Twitter for more live updates

Share this article


Popular Features

FEATURES | Published October 7th 2024, 4:04 pm

Margaret Ollivier: Ensuring Respect and Inclusivity at Expect Ltd

FEATURES | Published September 16th 2024, 11:11 am

Andrew Martin: Steering the Course of Planning and Development

FEATURES | Published July 26th 2024, 7:07 am

Paul Bowley: Transforming Lives with Abbeycare Group

© Copyright 2024, Leaders of Great Britain.